Evaluation of the efficacy of oral swabs and oropharyngeal saliva as diagnostic tools for COVID-19

Not Applicable

• Conditions: COVID-19/ Practical and safe diagnostic tools; COVID-19; Diagnostic tool; Salivary swabs; B34.9

• Registration Number: LBCTR2021044780
• Lead Sponsor: ebanese University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-18
• Study Completion: 2021-06-18
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

1. COVID-19 Positive Tested Patients from all nationalities, presenting mild or moderate cases (not intubated and not under oxygen).
2. Patients whom (or guardians) give written informed consent.

Exclusion Criteria

1. COVID-19 Positive tested patients presenting disabilities (Mental retardation-Physical invalidity-Psychological,troubles- Cognitive troubles affecting the capacity of discernation).
2. Patients presenting hyposalivation.
3. Patients whom (or guardians) decline written informed consent.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ame: To detect the efficacy of oral swabs and oropharyngeal spitted saliva as a diagnostic tool for the COVID-19.;Timepoints: End of study;Measure: Salivary SARS-CoV-2 Ct from salivary swabs

Secondary Outcome Measures

Name	Time	Method
ame: To compare Salivary SARS-CoV-2 (from lingual,sublingual and oropharyngeal spitted saliva) cycle threshold (Ct) to nasopharyngeal SARS-CoV-2 Ct ;Timepoints: End of study;Measure: Nasophayngeal SARS-CoV-2 Ct